Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity.
Marina MachadoMaricela ValerioAna Álvarez-UríaMaría OlmedoCristina VeintimillaBelén PadillaSofía De la VillaJesus Vicente GuineaPilar EscribanoMaría Jesús Ruiz-SerranoElena ReigadasRoberto AlonsoJosé Eugenio GuerreroJavier HortalEmilio BouzaPatricia Muñoznull nullPublished in: Mycoses (2020)
COVID-19-associated pulmonary aspergillosis must be considered a serious and potentially life-threatening complication in patients with severe COVID-19 receiving immunosuppressive treatment.